Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Psychotherapy Intervention for Latinos With Adv Cancer

Not Applicable

Recruiting

Conditions: Solid Tumor, Unspecified, Adult
Solid Tumor, Adult
Solid Tumor

Interventions: Behavioral: Meaning Centered Psychotherapy for Latinos
Behavioral: Functional Assessment of Cancer Therapy - Spiritual Well-Being Scale
Behavioral: Meaning Centered Psychotherapy for Latinos for Waitlist Control Patients
Behavioral: Pre-assessment questionnaire

First Posted Date: 2020-09-03

Last Posted Date: 2025-05-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 285

Registration Number: NCT04537936

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
MSK at Ralph Lauren, New York, New York, United States
🇺🇸
Lincoln Medical and Mental Health Center, Bronx, New York, United States

and more 1 locations

ZW25 in Women With Endometrial Cancers

Phase 2

Completed

Conditions: Endometrial Cancer
Carcinosarcoma

Interventions: Drug: ZW25

First Posted Date: 2020-08-14

Last Posted Date: 2025-05-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 16

Registration Number: NCT04513665

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited protocol activities), Basking Ridge, New Jersey, United States

and more 4 locations

Iomab-ACT: a Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

Early Phase 1

Recruiting

Conditions: B-ALL
DLBCL
Dlbcl-Ci
DLBCL Activated B-Cell Type
B ALL
DLBCL Unclassifiable
DLBCL, Nos Genetic Subtypes
DLBCL Germinal Center B-Cell Type
HGBL, Nos
Diffuse Large B-cell Lymphoma

Interventions: Drug: 131-I Apamistamab
Biological: CAR T-cell

First Posted Date: 2020-08-13

Last Posted Date: 2025-03-11

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 6

Registration Number: NCT04512716

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre, New York, United States

and more 4 locations

A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection

Phase 2

Terminated

Conditions: Gastric Tumor
Esophageal Cancer
Gastroesophageal Junction Tumor
Esophagogastric Tumors
Gastric Cancer
Esophageal Neoplasms
Esophageal Tumor
GastroEsophageal Cancer
Gastroesophageal Junction Adenocarcinoma
Gastroesophageal Junction Cancer

Interventions: Drug: Trastuzumab
Drug: Pembrolizumab

First Posted Date: 2020-08-12

Last Posted Date: 2023-02-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1

Registration Number: NCT04510285

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack, New York, United States

and more 4 locations

Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria

Not Applicable

Recruiting

Conditions: Breast Cancer

Interventions: Other: Ultrasound-guided breast biopsy training program
Procedure: US-guided breast biopsy

First Posted Date: 2020-08-06

Last Posted Date: 2024-08-12

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 600

Registration Number: NCT04501419

Locations: 🇳🇬
Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC), Ile-Ife, Nigeria

Naxitamab and GM-CSF in People With Neuroblastoma

Conditions: High-Risk Neuroblastoma

First Posted Date: 2020-08-06

Last Posted Date: 2022-12-08

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT04501757

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide

Phase 2

Active, not recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Lenalidomide
Drug: Daratumumab
Behavioral: Questionnaires
Other: Dietary Intervention

First Posted Date: 2020-08-04

Last Posted Date: 2025-05-25

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 95

Registration Number: NCT04497961

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

Collection of Information to Better Understand Young Onset Colorectal Cancer

Recruiting

Conditions: Colorectal Carcinoma
Colorectal Cancer

Interventions: Other: Risk Factor Questionnaire

First Posted Date: 2020-07-28

Last Posted Date: 2025-05-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1366

Registration Number: NCT04489238

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

and more 5 locations

Communication Training for Cancer Patients, Their Caregivers, and Their Doctors

Completed

Conditions: Communication and Illness Understanding

First Posted Date: 2020-07-21

Last Posted Date: 2025-05-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 55

Registration Number: NCT04479605

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer

Phase 2

Completed

Conditions: Multiple Myeloma
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
HDT-AHCT

Interventions: Drug: Romiplostim

First Posted Date: 2020-07-20

Last Posted Date: 2024-02-14

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 62

Registration Number: NCT04478123

Locations: 🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

and more 4 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy